GlassScriptPhysician profile
Chanel J Perkins
NPI 1295979391
$1,179.81
in general payments reported to CMS, 2019-2025
18 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.97 · 2020: $118 · 2021: $23.00 · 2022: $238 · 2023: $222 · 2024: $358 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $787.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $230.58 | 2020-2022 | |
| Boston Scientific Corporation | $139.79 | 2024 | Eluvia |
| Treace Medical Concepts, INC. | $121.02 | 2022-2024 | |
| Abbott Laboratories | $119.49 | 2025 | Freestyle Libre 3 |
| W. L. Gore & Associates, INC. | $94.08 | 2023 | Gore Viabahn Endoprosthesis With Heparin |
| Bone Support INC. | $75.39 | 2024 | Cerament G, Ceramentbone Void Filler |
| Xeris Pharmaceuticals, INC. | $65.72 | 2022-2024 | Recorlev |
| Lilly USA, LLC | $59.40 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Dexcom, INC. | $45.59 | 2021-2024 | Dexcom G6 Transmitter |
| Stryker Corporation | $44.11 | 2024 | N/A |
| Embecta Corp. | $43.33 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Halozyme INC | $32.67 | 2023 | |
| Kyowa Kirin, INC. | $22.60 | 2025 | |
| Paratek Pharmaceuticals, INC. | $21.55 | 2025 | Nuzyra |
| Astrazeneca Pharmaceuticals LP | $20.24 | 2023 | Farxiga |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $16.99 | 2025 | Purified Cortrophin Gel |
| Corcept Therapeutics | $14.29 | 2023 | Korlym |
| Amgen INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanel Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.